JP Morgan Chase
CTXR icon

JP Morgan Chase’s Citius Pharmaceuticals CTXR Stock Holding History

JP Morgan Chase’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69 Hold
120
– – ﹤0.01% 7565
2026
Q1 		$82 Hold
120
– – ﹤0.01% 7323
2025
Q4 		$93 Hold
120
– – ﹤0.01% 7219
2025
Q3 		$149 Hold
120
– – ﹤0.01% 7141
2025
Q2 		$191 Sell
120
-16
-12% -$15 ﹤0.01% 6785
2025
Q1 		$203 Buy
136
+12
+10% +$29 ﹤0.01% 6797
2024
Q4 		$496 Buy
124
+2
+2% +$13 ﹤0.01% 6802
2024
Q3 		$1.52K Hold
122
– – ﹤0.01% 6665
2024
Q2 		$1.77K Sell
122
-1,927
-94% -$34.5K ﹤0.01% 6546
2024
Q1 		$46K Sell
2,049
-1,141
-36% -$20.8K ﹤0.01% 5983
2023
Q4 		$60.3K Hold
3,190
– – ﹤0.01% 5939
2023
Q3 		$54.6K Sell
3,190
-731
-19% -$17.4K ﹤0.01% 5774
2023
Q2 		$118K Buy
3,921
+3,918
+130,600% +$129K ﹤0.01% 5389
2023
Q1 		$0 Hold
3
– – ﹤0.01% 6775
2022
Q4 		$0 Hold
3
– – ﹤0.01% 6610
2022
Q3 		$0 Hold
3
– – ﹤0.01% 6510
2022
Q2 		$0 Sell
3
-2,325
-100% -$63.7K ﹤0.01% 6523
2022
Q1 		$104K Buy
2,328
+581
+33% +$22.9K ﹤0.01% 5488
2021
Q4 		$67K Sell
1,747
-1,828
-51% -$82.9K ﹤0.01% 5839
2021
Q3 		$181K Sell
3,575
-2,568
-42% -$129K ﹤0.01% 5289
2021
Q2 		$535K Buy
+6,143
New +$369K ﹤0.01% 4649

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM

JP Morgan Chase's CTXR Position: Q2 2026 in Review

JP Morgan Chase held its Citius Pharmaceuticals (CTXR) position steady in Q2 2026 at 120 shares worth $69. The position accounts for ﹤0.01% of the portfolio, ranked #7565.

JP Morgan Chase first reported a position in CTXR in Q2 2021 and has held it in 21 quarters since. The position peaked at $535K in Q2 2021. 43 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

  • JP Morgan Chase held 120 shares of Citius Pharmaceuticals worth $69 as of Q2 2026.
  • JP Morgan Chase left its Citius Pharmaceuticals share count unchanged in Q2 2026.
  • Citius Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7565 holding.
  • JP Morgan Chase first reported a position in Citius Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • JP Morgan Chase's Citius Pharmaceuticals position peaked at $535K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.